Research Conducted and Supported by the National Institutes of Health (NIH) in Addressing Zika Virus Disease. Testimony before the House Democratic Steering and Policy Committee.
Anthony S. Fauci, M.D., NIAID Director
Dr. Fauci was appointed Director of NIAID in 1984. He oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.
The NIAID budget for fiscal year 2016 is approximately $4.6 billion. Dr. Fauci has advised five Presidents and the U.S. Department of Health and Human Services on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.
about fauci.jpg
Credit:
Anthony S. Fauci, M.D.
NIAID Director
Profiles, Awards, and Honors
Publications and Articles
September 29, 2016
Considerations for Developing a Zika Virus Vaccine
Considerations for Developing a Zika Virus Vaccine
September 20, 2016
Antimicrobial Resistance
Antimicrobial Resistance
Dr. Fauci in the News
Congressional Testimony
Dr. Fauci's Statement for the Record Submitted to the Senate Subcommittee on Labor-HHS-Education Appropriations for Hearing on National Institutes of Health Fiscal Year 2017 Budget.
Laboratory of Immunoregulation
Dr. Fauci also is the long-time chief of the Laboratory of Immunoregulation. He has made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated and infectious diseases. He helped pioneer the field of human immunoregulation by making important basic scientific observations that underpin the current understanding of the regulation of the human immune response.